TABLE 1. One-year life-table discontinuation rates per 100 women, with different injectable hormonal contraceptives.
|
Method |
(Reference) |
Women-months |
Pregnancy |
Amenorrhea |
Bleeding |
All Reasons |
|
3-Monthly Injectable |
||||||
|
DMPA 150 |
(9) |
20,550 |
0.10 |
11.9 |
15.0 |
51.4 |
|
DMPA 150 |
(8) |
4,782 |
0.7 |
11.5 |
9.3 |
28.8 |
|
DMPA 150 |
(10) |
5,429 |
0 |
12.5 |
13.3 |
41.2 |
|
2-Monthly Injectable |
||||||
|
NET-EN 200 |
(9) |
10,361 |
0.4 |
6.8 |
13.6 |
49.7 |
|
NET-EN 200 |
(1) |
4,101 |
1.1 |
6.9 |
14.8 |
35.7 |
|
NET-EN 200 |
(WHO unpub.) |
1,445 |
0 |
4.5 |
9.8 |
42.0 |
|
Once-a-month Injectables |
||||||
|
DMPA 25/E2 Cyp 5 |
(12) |
10,969 |
0 |
2.1 |
6.3 |
35.5 |
|
DMPA 25/E2 Cyp 5 |
(5) |
19,765 |
0.1 |
5.2 |
12.7 |
26.4 |
|
NET-EN 50/E2 Val 5 |
(12) |
10,608 |
0.2 |
1.6 |
7.5 |
36.8 |
|
NET-EN 50/E2 Val 5 |
(5) |
20,688 |
0.3 |
0.8 |
7.9 |
18.8 |
|
NET-EN 50/E2 Val 5 |
(1) |
3,716 |
0.2 |
4.2 |
12.0 |
44.1 |
|
17-OH-P Cap 250/E2 Val 5 |
(5) |
10,459 |
0.8 |
0.7 |
12.6 |
20.4 |
Note: Cyp, cypionate; DMPA, depot-medroxyprogesterone acetate; E2, estradiol;
NET-EN, norethisterone enanthate; Val, valerate; 17-OH P Cap, 17-hydroxyprogesterone caproate.